Lawrence Gibbs - Universal Health Independent Director
UHS Stock | USD 181.85 4.54 2.56% |
Director
Mr. Lawrence S. Gibbs is an Independent Director of Universal Health Services, Inc., since 2011. He was Chief Investment Officer at Erdos Capital since January 2017. Previously served in various portfolio manager and chief investment officer roles including portfolio manager at JP Morgan Chase Bank NA. since 2011.
Age | 48 |
Tenure | 13 years |
Address | Universal Corporate Center, King of Prussia, PA, United States, 19406-0958 |
Phone | 610 768 3300 |
Web | https://www.uhs.com |
Universal Health Management Efficiency
The company has Return on Asset of 0.0535 % which means that on every $100 spent on assets, it made $0.0535 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1182 %, implying that it generated $0.1182 on every 100 dollars invested. Universal Health's management efficiency ratios could be used to measure how well Universal Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to gain to 0.1 in 2024, whereas Return On Assets are likely to drop 0.04 in 2024. At this time, Universal Health's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 12.1 B in 2024, whereas Intangible Assets are likely to drop slightly above 85.3 M in 2024.Similar Executives
Showing other executives | DIRECTOR Age | ||
Leslie Heisz | Edwards Lifesciences Corp | 60 | |
Yair Rabinovitch | Medigus Ltd ADR | 67 | |
Scott Burell | Microbot Medical | 52 | |
Efrat Venkert | Medigus Ltd ADR | 46 | |
Yair Rabinowitch | Medigus Ltd ADR | 71 | |
Prattipati Laxminarain | Microbot Medical | 59 | |
Doron Birger | Medigus Ltd ADR | 66 | |
Kieran Gallahue | Edwards Lifesciences Corp | 57 | |
Ramona Sequeira | Edwards Lifesciences Corp | 55 | |
Wesley Schack | Edwards Lifesciences Corp | 74 | |
John Cardis | Edwards Lifesciences Corp | 73 | |
Barbara McNeil | Edwards Lifesciences Corp | 74 | |
Moshe Shoham | Microbot Medical | 64 | |
Alfred Lim | EUDA Health Holdings | 72 | |
Jeremy Starkweather | Medigus Ltd ADR | 42 | |
Yuval Yanai | Medigus Ltd ADR | 65 | |
Aviel Shapira | Medigus Ltd ADR | 61 | |
Solomon Mayer | Microbot Medical | 62 | |
Nicholas Valeriani | Edwards Lifesciences Corp | 64 | |
Martin Madden | Microbot Medical | 57 | |
Yoseph Bornstein | Microbot Medical | 65 |
Management Performance
Return On Equity | 0.12 | ||||
Return On Asset | 0.0535 |
Universal Health Services Leadership Team
Elected by the shareholders, the Universal Health's board of directors comprises two types of representatives: Universal Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Universal. The board's role is to monitor Universal Health's management team and ensure that shareholders' interests are well served. Universal Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Universal Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Matthew Peterson, Executive Vice President of the company and President of Behavioral Health Division | ||
Geraldine Geckle, Senior Resources | ||
Matt Peterson, Executive Vice President of the company and President of Behavioral Health Division | ||
John Herrell, Independent Presiding Director | ||
Marc Miller, President, Director and Member of Fin. Committee | ||
Matthew Klein, Senior Counsel | ||
Jim Clark, Senior Division | ||
Debra Osteen, Sr. VP and President of Behavioral Health Care Division | ||
Edward Sim, Executive Division | ||
Steve Filton, Chief Financial Officer, Executive Vice President, Secretary | ||
Karen Sterner, IR Contact Officer | ||
Lynda Smirz, Chief VP | ||
Elliot Sussman, Independent Director | ||
Lawrence Gibbs, Independent Director | ||
Warren Nimetz, Director | ||
Victor Radina, Senior Development | ||
Robert Hotz, Independent Director | ||
Anthony Pantaleoni, Director | ||
Steven Filton, CFO, Senior Vice President Secretary | ||
Marvin Pember, Executive Vice President, President of Acute Care Division | ||
Eileen McDonnell, Lead Independent Director | ||
Alan Miller, Executive Chairman, CEO, Member of Executive Committee and Member of Fin. Committee | ||
Michael Nelson, Senior Services | ||
Maria Singer, Independent Director | ||
Thomas Day, Senior Division |
Universal Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Universal Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.12 | ||||
Return On Asset | 0.0535 | ||||
Profit Margin | 0.05 % | ||||
Operating Margin | 0.09 % | ||||
Current Valuation | 17.47 B | ||||
Shares Outstanding | 59.97 M | ||||
Shares Owned By Insiders | 4.03 % | ||||
Shares Owned By Institutions | 98.83 % | ||||
Number Of Shares Shorted | 1.39 M | ||||
Price To Earning | 13.68 X |
Universal Health Investors Sentiment
The influence of Universal Health's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Universal. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Universal Health's public news can be used to forecast risks associated with an investment in Universal. The trend in average sentiment can be used to explain how an investor holding Universal can time the market purely based on public headlines and social activities around Universal Health Services. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Universal Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Universal Health's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Universal Health's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Universal Health.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Universal Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Universal Health's short interest history, or implied volatility extrapolated from Universal Health options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.MSFT | Microsoft | |
GOOG | Alphabet Class C | |
S | SentinelOne |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Universal Health Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Universal Health Services information on this page should be used as a complementary analysis to other Universal Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Universal Stock analysis
When running Universal Health's price analysis, check to measure Universal Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universal Health is operating at the current time. Most of Universal Health's value examination focuses on studying past and present price action to predict the probability of Universal Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universal Health's price. Additionally, you may evaluate how the addition of Universal Health to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |
Is Universal Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Universal Health. If investors know Universal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Universal Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.297 | Dividend Share 0.8 | Earnings Share 10.24 | Revenue Per Share 206.027 | Quarterly Revenue Growth 0.074 |
The market value of Universal Health Services is measured differently than its book value, which is the value of Universal that is recorded on the company's balance sheet. Investors also form their own opinion of Universal Health's value that differs from its market value or its book value, called intrinsic value, which is Universal Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Universal Health's market value can be influenced by many factors that don't directly affect Universal Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Universal Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Universal Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Universal Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.